The segmentation of the Mental Health Market by disorder and service type highlights the most prevalent conditions driving service demand and the dominant modes of treatment delivery, creating a clear focus for both pharmacological and non-pharmacological interventions, and Depression and Anxiety Disorders collectively represent the largest segment by disorder, accounting for the majority of the revenue share due to their high global prevalence and significant economic impact, as consistently reported in market breakdowns within the Mental Health Market.

The high burden of depression, leading with a significant revenue share (estimated at nearly 39% in 2024), is closely followed by anxiety disorders, both of which are exacerbated by modern stressors, lifestyle factors, and the lingering psychological effects of global events. The co-management of comorbid conditions, such as the high incidence of substance use disorders among adults with mental illnesses, further increases the complexity and volume of treatment required across the segment, driving demand for integrated care pathways that address both conditions simultaneously.

By service type, Out-patient Counselling/Psychotherapy holds the largest market share (estimated at over 42% in 2024), underscoring the enduring role of traditional face-to-face and virtual talk therapy as the cornerstone of mental health treatment. This segment’s dominance reflects the fact that psychotherapy remains the primary first-line intervention for a wide range of common mental illnesses. However, the fastest growth is observed in the digital and tele-psychiatry segments, which challenge the outpatient model by offering greater convenience. Meanwhile, segments treating severe mental illnesses, such as schizophrenia and bipolar disorder, continue to rely heavily on Inpatient Hospital Treatment Services and the use of long-acting injectable medications, necessitating specialty network rollouts.

Related Reports